Drugs.com - FDA MedWatch Alerts

Mxbbb Issues Voluntary Nationwide Recall of Umary Acid Hyaluronic Due to the Presence of Diclofenac and Omeprazole

Audience: Healthcare Provider, Pharmacy, Consumer November 20, 2024 -- MXBBB is voluntarily recalling 1 lot of UMARY ACID HYALURONIC, 30 CAPLETS 850 MG to the consumer level. The products have been found to have omeprazole and diclofenac. FDA...

Feb 9, 2025 - 21:44
 0
Mxbbb Issues Voluntary Nationwide Recall of Umary Acid Hyaluronic Due to the Presence of Diclofenac and Omeprazole
Audience: Healthcare Provider, Pharmacy, Consumer November 20, 2024 -- MXBBB is voluntarily recalling 1 lot of UMARY ACID HYALURONIC, 30 CAPLETS 850 MG to the consumer level. The products have been found to have omeprazole and diclofenac. FDA...
Read More

Tags:

Previous Article

FDA Investigating Serious Risk of Hematologic Malignancy Following Skysona (eliv...

Next Article

VitalityVita Issues Voluntary Nationwide Recall of VitalityXtra and PeakMax Caps...

Related Posts

VitalityVita Issues Voluntary Nationwide Recall of VitalityXtra and PeakMax Capsules Due to the Presence of Undeclared Sildenafil and Diclofenac

VitalityVita Issues Voluntary Nationwide Recall of Vita...

Feb 9, 2025  0

FDA Adds Boxed Warning to Veozah (fezolinetant) to Highlight the Known Risk of Rare But Serious Liver Injury

FDA Adds Boxed Warning to Veozah (fezolinetant) to High...

Feb 9, 2025  0

Alcon Laboratories Issues Voluntary Nationwide Recall of One Lot of Systane Lubricant Eye Drops Ultra PF Due to Fungal Contamination

Alcon Laboratories Issues Voluntary Nationwide Recall o...

Feb 9, 2025  0